Cardiac Stents Market Research Report: Information by Material (Metal and Polymer), Application (Coronary Artery Disease and Periphery Artery Disease), End-Use (Hospitals and Clinics, Cardiovascular Centers, Research Institutes and Organizations and Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025
Market Analysis
The Global Cardiac Stent Market is predicted to grow at a 9.6% CAGR between 2017-2023, states the latest Market Research Future (MRFR) report. Absorbable Heart stents are meant for patients with relatively noncomplex blockages and low risk. It gets dissolved in the body with time and its possible advantages include fewer risks compared to traditional metal stents and reduced repeat procedures. Absorbable stents are generally made of polymers or metals. The metallic stents are generally made of iron and its alloys, iron, magnesium, and zinc. Of the two, the polymeric stents are widely used for their ability to maintain a strong scaffold.
Various factors are propelling the Cardiac Stents Market growth. Some of these factors, as per the latest Market Research Future report, include increasing psychological and physical stress, changing lifestyle, rising number of cardiac procedures, rise in patient pool, and burgeoning demand for absorbable heart stents. Additional factors propelling the Cardiac Stents Marketgrowth include technological advancements in heart stents, rising incidence of cardiac diseases, lack of physical exercise, and increasing unhealthy habits.
On the contrary, the high cost of cardiac surgery and the price of stents in some developed countries are factors that may hamper the Cardiac Stents Marketgrowth during the forecast period.
Market Segmentation
The MRFR report provides an all-inclusive segmental analysis of the Cardiac Stents Marketon the basis of end use, application, and material.
By material, the Cardiac Stents Marketis segmented into polymer and metal. Of these, the polymer segment will lead the market over the forecast period owing to the rising applications as well as the use of stents that are polymer-based.
By application, the Cardiac Stents Marketis segmented into periphery artery disease and coronary artery disease. Of these, the coronary artery disease segment will dominate the market over the forecast period due to the increasing incidence of coronary diseases in geriatric individuals.
By end use, the Cardiac Stents Marketis segmented into research institutes and organizations, cardiovascular centers, hospitals and clinics, and others. Of these, hospitals and clinics will have the maximum share in the market during the forecast period owing to the increasing risk of peripheral artery disease and coronary artery disease coupled with a growing number of heart surgeries.
For More Information Visit @ https://www.marketresearchfuture.com/reports/absorbable-heart-stent-market-1175
Regional Analysis
By region, the Cardiac Stents Marketreport covers the latest trends and growth opportunities across the Americas, the Middle East and Africa, Europe, and the Asia Pacific. Of these, the Americas will spearhead the Cardiac Stents Marketduring the forecast period. Factors pushing the growth of the Cardiac Stents Marketin the region include increasing use of absorbable heart stents by healthcare physicians, preference of patients for minimally invasive therapies, increasing prevalence of chronic diseases, and favorable initiatives undertaken by the government for healthcare reforms. Canada and the US are the chief contributors in this region owing to the rising geriatric population suffering from obesity and diabetes, greater healthcare penetration, good reimbursement rates, and the presence of good hospitals, especially in the developed countries of the region.
In Europe, the Cardiac Stents Marketis predicted to have the second-largest share during the forecast period. Factors pushing the growth of the Cardiac Stents Marketin the region include the prevalence of peripheral artery disease (PAD) and coronary artery disease CAD), a huge patient pool, increasing healthcare penetration, and expanding medical devices industry. Germany is the main contributor in this region owing to the presence of a huge medical device industry, followed by France.
The Cardiac Stents Marketin the APAC region is predicted to experience faster growth during the forecast period. Factors pushing the growth of the Cardiac Stents Marketin the region include increasing incidence of chronic diseases, especially cardiovascular disease, large unmet needs, growing healthcare sector, and development of healthcare infrastructure. China, as well as India, are the chief contributors in this region.
The Cardiac Stents Marketin the MEA is predicted to have a substantial growth owing to the increasing use of surgical treatments for cardiovascular diseases.
Key Players
Notable players profiled in the Cardiac Stents Marketreport include Meril Life Sciences Pvt. Ltd, Terumo Medical Corporation, Medtronic, Boston Scientific Corporation, KYOTO MEDICAL PLANNING Co., Ltd., Braun Melsungen AG, Elixir Medical Corporation, REVA Medical, Inc., Biotronik, and Abbott Laboratories. Key players have incorporated different strategies to create a niche in the market, such as joint ventures, research, and development activities, collaborations, expansions, mergers and acquisitions, and more.
Market Analysis and Insights:- North America Cardiac Stents MarketNorth America Cardiac Stents Market By Type (Bare-Metal Stents, Drug-Eluting Stents, Bio Absorbable Stents), By Mode of Delivery (Balloon-Expandable Stents, Self-Expanding Stents), By Material (Metallic Stents, Other Stents), By End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), Country (U.S., Canada, Mexico) - Industry Trends and Forecast to 2026Market Analysis: North America Cardiac Stents MarketNorth America cardiac stents market is registering substantial CAGR in the forecast period of 2019-2026.
This rise in the market value can be attributed to the rise in elderly population, rising incidence of cancer and technical developments in ostomy products.Market Definition: North America Cardiac Stents MarketCardiac stents are tiny flexible pipes used in individuals with Coronary Artery Disease (CAD) to treat enclosed and barred coronary artery.
It reduces chest pain symptoms (angina) and helps treat a heart attack.
They consist of metal mesh and during a technique known as percutaneous coronary intervention (PCI) or angioplasties have been deployed in restricted coronary arteries.Get More Insight About the North America Cardiac Stents Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-cardiac-stents-market Market DriversTechnological advancements in the fields of cardiac stents is boosting the growth of the marketIncreased coronary artery diseases incidence and subsequent PCI growth is driving the growth of the marketGrowing demand for minimally invasive procedures is surging the growth of the marketIncreasing geriatric population is propelling the growth of the marketMarket RestraintsAlternative coronary artery disease therapy availability is hampering the growth of the marketProduct approval strict regulations is hindering the growth of the marketProduct failure and cancellation of the product is restricting the growth of the market Know More About this Report @ https://www.databridgemarketresearch.com/reports/north-america-cardiac-stents-market Segmentation: North America Cardiac Stents MarketBy TypeBare-Metal StentsDrug-Eluting StentsBio absorbable StentsBy Mode of DeliveryBalloon-Expandable StentsSelf-Expanding StentsBy MaterialMetallic StentsCobalt ChromiumPlatinum ChromiumNickel TitaniumStainless SteelOther StentsBy End UserHospitalsCardiac CentersAmbulatory Surgical CentersBy CountryU.S.CanadaMexicoKey Developments in the Market:In May 2019, Boston Scientific announced the approval by the U.S. Food and Drug Administration (FDA) of the VICI VENOUS STENT system for the treatment of the disease of iliofemoral blood venous disease when blood flow in deep veins in a pelvic area is blocked by blood clots and anatomical abnormalities compressed.
For those with venous obstructive disease, this stent can affect their quality of life without optimized treatment options for the disease.In April 2019, BIOTRONIK announced the commercial launch of the coronary stent system covered by PK Papyrus to be used in acute coronary perforations emergency treatment in the United States.
The report includes market shares of Cardiac stents market for Asia-Pacific.Key Market Competitors:Few of the major market competitors currently working in the North America cardiac stents market are Medtronic, Abbott, Boston Scientific Corporation, Biosensors International Group, Ltd., B. Braun Melsungen AG, Biotronik, Terumo Corporation, MicroPort Scientific Corporation, Meril Life Sciences Pvt.
Market Analysis and Insights:- North America Cardiac Stents MarketNorth America Cardiac Stents Market By Type (Bare-Metal Stents, Drug-Eluting Stents, Bio Absorbable Stents), By Mode of Delivery (Balloon-Expandable Stents, Self-Expanding Stents), By Material (Metallic Stents, Other Stents), By End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), Country (U.S., Canada, Mexico) - Industry Trends and Forecast to 2026Market Analysis: North America Cardiac Stents MarketNorth America cardiac stents market is registering substantial CAGR in the forecast period of 2019-2026.
This rise in the market value can be attributed to the rise in elderly population, rising incidence of cancer and technical developments in ostomy products.Market Definition: North America Cardiac Stents MarketCardiac stents are tiny flexible pipes used in individuals with Coronary Artery Disease (CAD) to treat enclosed and barred coronary artery.
It reduces chest pain symptoms (angina) and helps treat a heart attack.
They consist of metal mesh and during a technique known as percutaneous coronary intervention (PCI) or angioplasties have been deployed in restricted coronary arteries.Get More Insight About the North America Cardiac Stents Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-cardiac-stents-market Market DriversTechnological advancements in the fields of cardiac stents is boosting the growth of the marketIncreased coronary artery diseases incidence and subsequent PCI growth is driving the growth of the marketGrowing demand for minimally invasive procedures is surging the growth of the marketIncreasing geriatric population is propelling the growth of the marketMarket RestraintsAlternative coronary artery disease therapy availability is hampering the growth of the marketProduct approval strict regulations is hindering the growth of the marketProduct failure and cancellation of the product is restricting the growth of the market Know More About this Report @ https://www.databridgemarketresearch.com/reports/north-america-cardiac-stents-market Segmentation: North America Cardiac Stents MarketBy TypeBare-Metal StentsDrug-Eluting StentsBio absorbable StentsBy Mode of DeliveryBalloon-Expandable StentsSelf-Expanding StentsBy MaterialMetallic StentsCobalt ChromiumPlatinum ChromiumNickel TitaniumStainless SteelOther StentsBy End UserHospitalsCardiac CentersAmbulatory Surgical CentersBy CountryU.S.CanadaMexicoKey Developments in the Market:In May 2019, Boston Scientific announced the approval by the U.S. Food and Drug Administration (FDA) of the VICI VENOUS STENT system for the treatment of the disease of iliofemoral blood venous disease when blood flow in deep veins in a pelvic area is blocked by blood clots and anatomical abnormalities compressed.
For those with venous obstructive disease, this stent can affect their quality of life without optimized treatment options for the disease.In April 2019, BIOTRONIK announced the commercial launch of the coronary stent system covered by PK Papyrus to be used in acute coronary perforations emergency treatment in the United States.
The report includes market shares of Cardiac stents market for Asia-Pacific.Key Market Competitors:Few of the major market competitors currently working in the North America cardiac stents market are Medtronic, Abbott, Boston Scientific Corporation, Biosensors International Group, Ltd., B. Braun Melsungen AG, Biotronik, Terumo Corporation, MicroPort Scientific Corporation, Meril Life Sciences Pvt.
